Clin2
NCT04661280Possibly a fitRecruiting

Donepezil compared with non-drug care for Alzheimer’s

Alzheimer Disease, Early Onset

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial compares donepezil (a medicine for Alzheimer’s symptoms) against a non-drug treatment plan. It aims to see which approach helps people with Alzheimer’s who still have measurable thinking ability and specific Alzheimer’s test results.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
240 people
Ages
50 years and older
Study type
Interventional

Who can take part

  • You have a confirmed diagnosis of Alzheimer’s disease based on specific guidelines.
  • You are age 50 or older.
  • Your thinking test (MMSE) is at least 10 at the start of the study.
  • Your spinal fluid tests (Aβ42 and/or Aβ40/Aβ42 ratio, and tau) are abnormal in a way linked to Alzheimer’s.
  • You speak French as your native language, and you have a family caregiver at home to help with the plan.
  • You should not be on certain heart-rhythm–affecting medicines or strong medication interactions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07221344Recruiting· Phase 1/Phase 2
Study of an experimental drug for early Alzheimer's disease

This study tests an investigational drug, ARO-MAPT-SC, which targets a protein involved in Alzheimer's disease. It is for people with early Alzheimer's to see if the drug is safe and can slow the disease.

East York, Ontario
NCT03454646Not yet recruiting· Phase 4
Alzheimer care comparison using dementia medicines

This study compares different treatment strategies for people newly diagnosed with Alzheimer disease using cholinesterase inhibitor medicines. It may help show which approach works best for mild to moderate Alzheimer symptoms and how well people can stay stable over time.

Amiens
NCT06687993Not yet recruiting· Phase 2
Testing a memory drug for women with anorexia

This trial tests whether donepezil, a medication used in memory disorders, can help women with the restrictive subtype of anorexia nervosa. It may improve symptoms by affecting brain chemicals related to appetite and mood.

NCT05592678Recruiting
Study brain and memory test changes in Alzheimer’s or mild issues

This study looks at how well people with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) perform on standardized memory/brain tests. It may help researchers understand changes over time, and whether certain types of brain signals or test results track with the condition.

San Antonio, Texas
NCT06041789Recruiting· Phase 2
Testing donepezil for bone health in memory loss

This study tests whether a memory medication called donepezil (Aricept) can help strengthen bones in people with memory problems. If you have mild cognitive impairment or dementia and are not already on a similar medication, you may be able to join.

Durham, North Carolina
NCT06518941Not yet recruiting· Phase 2
New medication for habit change in anorexia

This trial tests a medication (donepezil) to help people with anorexia nervosa change habits related to eating. The study wants to see if the medicine is safe and can help reduce restrictive eating patterns.

New York, New York

Hear when a new Alzheimer Disease, Early Onset trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.